This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. It is particularly significant in the development of small molecule drugs targeting neurological disorders, such as depression, anxiety, and other central nervous system (CNS) conditions. Its structure, featuring a cyclopropyl group and a fluoropyridine moiety, makes it a valuable building block for designing compounds with enhanced binding affinity and selectivity toward specific receptors or enzymes in the brain. Additionally, it has been explored in the research of potential therapies for inflammatory diseases due to its ability to modulate biological pathways involved in immune response. Its dihydrochloride salt form improves solubility and stability, making it suitable for further pharmacological studies and drug formulation processes.